# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025, Regulation 9: Amendment of regulation 56C


In regulation 56C (fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device)—
(a) in paragraph (1)—
(i) in sub-paragraph (a), for “£4,550” substitute “£4,953”;
(ii) in sub-paragraph (b), for “£10,604” substitute “£11,543”;
(b) in paragraph (2)—
(i) in sub-paragraph (a), for “£900” substitute “£980”;
(ii) in sub-paragraph (b), for “£2,451” substitute “£2,668”;
(c) in paragraph (3)—
(i) in sub-paragraph (a), for “£46,526” substitute “£50,644”;
(ii) in sub-paragraph (b), for “£11,551” substitute “£12,574”.

---
Source: https://www.legislation.gov.uk/uksi/2025/749/regulation/9 (the official version)
Page: https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/regulation-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

